Table 2_Plants used in medicines and foods in osteoporosis: mechanistic insights into bone

A review document synthesizes mechanistic and clinical evidence on plants used in medicines and foods for osteoporosis management. The document, authored by Mingjun Wang and licensed under CC-BY-4.0, was last updated on June 1, 2026. It discusses osteoprotective metabolites and the need for large-scale randomized controlled trials.

Use Cases

• Literature review on osteoprotective plant metabolites based on the described flavonoids, polysaccharides, glycosides, and coumarins.
• Analysis of bone-remodeling pathways based on the described Wnt/β-catenin and BMP/SMAD signaling mechanisms.
• Evaluation of clinical trial evidence gaps for plant-based therapies based on the call for large-scale RCTs.

Strengths

• The document is openly licensed under CC-BY-4.0.
• It provides a synthesized review of both mechanistic pathways and clinical evidence.

Limitations

• The dataset is a 25.2 KB DOCX file, indicating a very limited scope of content.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Likely a literature review authored by an individual researcher.

Freshness

Last updated 2026-06-01 05:23:29; freshness should be verified.